Mounjaro Injections: Weekly Cadence and Format Basics

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This page belongs to the PlexusDx Education Hub, where we translate GLP-1 science, weight-management options, and the genetics underneath them into plain language. Explore the full Peptides & GLP-1 library.

The weekly rhythm at the center

The defining feature of Mounjaro injections is cadence: once weekly. As of April 2026, Mounjaro (tirzepatide) is available only as a once-weekly subcutaneous injection, with no FDA-approved oral form. That weekly beat is not incidental; it reflects how the molecule is formulated to work over a seven-day window. Eli Lilly's orforglipron, an investigational oral non-peptide small-molecule GLP-1 receptor agonist, has Phase 3 data but is not FDA-approved as of April 2026.

Why weekly injection instead of daily pills

Injectable GLP-1 receptor agonists deliver predictable bioavailability and generally dose once weekly (liraglutide is the once-daily exception). A peptide taken by mouth has to survive gastric digestion, which is why oral options are harder to engineer. Rybelsus, oral semaglutide, manages it with an absorption enhancer (SNAC) and a strict fasting requirement, and it is labeled for type 2 diabetes rather than weight management.

Adherence in the real world

Which cadence suits a person depends on preference, comfort with injections, timing demands, and lifestyle. Head-to-head efficacy data between oral and injectable semaglutide in chronic weight management is limited, so the weekly-injection choice is often about fit as much as data.

The labeled dose ladder, as reference

These figures are label facts, not directions. Injectable tirzepatide titrates per label from 2.5 mg weekly toward higher amounts, up to 15 mg for Mounjaro and Zepbound. Injectable semaglutide titrates from 0.25 mg weekly (Ozempic up to 2 mg, Wegovy up to 2.4 mg). Rybelsus opens at 3 mg daily and moves to 7 or 14 mg daily. A prescribing provider sets the individual schedule.

Cost and access notes

Oral and injection products carry separate pricing, distinct insurance rules, and different savings-program eligibility. PlexusDx publishes per-protocol pricing on its product pages, offering a Tirzepatide Injection protocol and a Tirzepatide Oral protocol inside its Weight Management Protocols.

The genetics under the weekly routine

The schedule is the visible part; biology is the hidden part. Variants in GLP1R, FTO, MC4R, and TCF7L2 shape baseline GLP-1 and energy-balance signaling regardless of cadence. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights. It does not predict response to any compound or format; it maps upstream context for a provider conversation.

What week-to-week consistency supports

The weekly rhythm only delivers its intended effect when it is kept consistently. The molecule is formulated around a seven-day interval, so a steady dosing day matters more than which day is chosen. People who anchor the injection to a fixed weekly cue tend to find the routine easier to sustain than those who leave it to memory.

Consistency also shapes how a clinician reads progress. Erratic timing muddies the picture of whether a given rung is doing its job, while a predictable cadence gives a provider cleaner information to work with when deciding on next steps. The mechanics of storage, handling, and what to do about a missed dose belong to the FDA patient instructions and the prescribing provider rather than a blog. The broader point is that the schedule is part of the therapy, not a formality wrapped around it.

None of this makes the weekly interval a burden for most people, but it does reframe it. A single dosing day is a commitment worth building a small ritual around, whether that is tying it to a recurring calendar reminder or a fixed weekend routine. The specifics of how to structure that belong to the plan a provider sets up, yet the principle is simple: treat the weekly beat as the backbone of the therapy rather than an incidental detail.

Frequently Asked Questions

How often are Mounjaro injections given?

Once weekly. As of April 2026, Mounjaro is available only as a once-weekly subcutaneous injection, and there is no FDA-approved oral form. Among GLP-1 receptor agonists, liraglutide is the once-daily exception, while Rybelsus, oral semaglutide, is daily and labeled for type 2 diabetes rather than weight management.

Why weekly injections rather than a daily tablet?

Peptides taken by mouth are largely broken down by stomach acid and digestive enzymes. Injection provides predictable bioavailability with a once-weekly cadence. Oral semaglutide reaches the bloodstream only through an absorption enhancer and strict fasting administration. That absorption challenge is the core reason the weekly-injection format remains dominant in the category.

What are the labeled dose steps?

As label reference only, injectable tirzepatide titrates from 2.5 mg weekly up to 15 mg for Mounjaro and Zepbound, and injectable semaglutide from 0.25 mg weekly toward Ozempic's 2 mg or Wegovy's 2.4 mg. Rybelsus runs 3 mg to 7 or 14 mg daily. These are not dosing instructions for any individual.

Does the genetic test set my weekly dose?

No. The Precision Peptide Genetic Test does not predict response to any compound or determine a dose. It analyzes pathway-level variants in GLP1R, FTO, MC4R, and TCF7L2 that shape baseline GLP-1 and energy-balance biology, offering upstream context that applies regardless of cadence or delivery format.

Keep reading across the PlexusDx Education Hub. Return to the Peptides & GLP-1 library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.